Description
Molnupiravir, an investigational oral antiviral, is indicated for restricted emergency use in India to treat adult patients with Covid-19 and with SpO2 93% and who have a high risk of disease progression.
₹1,700
Molnupiravir, an investigational oral antiviral, is indicated for restricted emergency use in India to treat adult patients with Covid-19 and with SpO2 93% and who have a high risk of disease progression.
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.